Reversing New Oral Anticoagulants: New Agents on the Horizon
Dr Goldhaber interviews Dr Pollack about the REVERSE-AD study evaluating a new dabigatran reversal agent and what the future holds for other NOAC reversal agents.
Source: Medscape Critical Care Podcast - Category: Intensive Care Authors: Medscape Source Type: podcasts